'Phase ii trials' diaporamas de présentation

Development And Classification Of A Medicine

Development And Classification Of A Medicine. Niall Byrne Wednesday 30 th January 2012. Lecture plan. Development of a medicine: How can we categorise drugs? How do drugs cause their effects? Specific receptors: lock & key Non-specific effects Pharmacokinetics. Introduction.

893 views • 65 slides

Post?p w onkologii - nowe techniki, nowe leki

Post?p w onkologii - nowe techniki, nowe leki. Rados?aw M?dry Katedra i Klinika Onkologii Uniwersytety Medycznego im. K. Marcinkowskiego w Poznaniu. Cancer Treatment Today. Surgery Radiation Systemic treatment: Cytotoxic Chemotherapy Hormone therapy Immunotherapy Non-cytotoxic therapy.

564 views • 55 slides

Are There Better Alternatives to Phase III Clinical Trials: Con

Are There Better Alternatives to Phase III Clinical Trials: Con. Nevin Murray. A Short History of Clinical Trials. Theoretical rationale sufficient. Case Reports. James Lind: A Treatise of the Scurvy, 1753 . Claude Bernard 1813-1878: observations in groups rather than case reports.

698 views • 51 slides

CHEMOPREVENTION: PRINCIPLES AND PROSPECTS

CHEMOPREVENTION: PRINCIPLES AND PROSPECTS. Gary D. Stoner, Ph.D. Department of Internal Medicine College of Medicine and Public Health The Ohio State University. Strategies for Cancer Prevention. Reduce Exposure to Environmental Carcinogens Identify Individuals at High Risk

669 views • 46 slides

Clinical Trials

Clinical Trials. The Way We Make Progress Against Disease. What Are Clinical Trials?. Research studies involving people Try to answer scientific questions and find better ways to prevent, diagnose, or treat disease. Why Is Participation in Clinical Trials Important?.

814 views • 31 slides

Patient Reported Outcomes as Endpoints in Lung Cancer and Thoracic Malignancies

Treatments and Agents Vary in their Side- Effects and Risk Profiles ... benefits associated with anti-cancer treatments, when compared with patient self-reports ...

901 views • 30 slides

410 views • 19 slides

Trials Accelerating Research : Approaches that Work XVI International Aids Conference

Responsibilities of state, community and private sector on research ethic Policy : looking back on recent CCR5 antagonists Hugues Fischer, TRT-5 (French Cab), Act Up-Paris, Paris, France. Trials Accelerating Research : Approaches that Work XVI International Aids Conference

94 views • 9 slides